Robin J. Lurvink

1.2k total citations
26 papers, 391 citations indexed

About

Robin J. Lurvink is a scholar working on Surgery, Emergency Medicine and Hepatology. According to data from OpenAlex, Robin J. Lurvink has authored 26 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 12 papers in Emergency Medicine and 10 papers in Hepatology. Recurrent topics in Robin J. Lurvink's work include Intraperitoneal and Appendiceal Malignancies (23 papers), Appendicitis Diagnosis and Management (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (10 papers). Robin J. Lurvink is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (23 papers), Appendicitis Diagnosis and Management (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (10 papers). Robin J. Lurvink collaborates with scholars based in Netherlands and Belgium. Robin J. Lurvink's co-authors include Ignace H. J. T. de Hingh, Felice N. van Erning, Johanna W. van Sandick, Simon W. Nienhuijs, Koen P. Rovers, Jacobus W. A. Burger, Checca Bakkers, Willem J. Koemans, Rob H.A. Verhoeven and Cecile Grootscholten and has published in prestigious journals such as Cancer Research, Scientific Reports and Annals of Oncology.

In The Last Decade

Robin J. Lurvink

23 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin J. Lurvink Netherlands 11 291 132 109 107 95 26 391
Koen P. Rovers Netherlands 16 458 1.6× 90 0.7× 190 1.7× 253 2.4× 113 1.2× 36 571
Alexander Kerscher Germany 11 430 1.5× 106 0.8× 160 1.5× 233 2.2× 99 1.0× 20 535
Isabelle Sourrouille France 9 216 0.7× 119 0.9× 42 0.4× 66 0.6× 244 2.6× 30 412
Uwe Maeder Germany 9 227 0.8× 67 0.5× 74 0.7× 98 0.9× 183 1.9× 10 476
A. Garofalo Italy 12 469 1.6× 121 0.9× 184 1.7× 261 2.4× 56 0.6× 24 552
Elia Poiasina Italy 11 377 1.3× 163 1.2× 80 0.7× 107 1.0× 134 1.4× 25 550
François-Noël Gilly France 12 171 0.6× 197 1.5× 67 0.6× 67 0.6× 96 1.0× 20 373
Tommaso Cioppa Italy 12 234 0.8× 79 0.6× 103 0.9× 161 1.5× 103 1.1× 20 372
Eva V. E. Madsen Netherlands 14 284 1.0× 112 0.8× 69 0.6× 111 1.0× 139 1.5× 49 488
Stylianos Giassas Greece 8 318 1.1× 121 0.9× 255 2.3× 121 1.1× 158 1.7× 20 493

Countries citing papers authored by Robin J. Lurvink

Since Specialization
Citations

This map shows the geographic impact of Robin J. Lurvink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin J. Lurvink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin J. Lurvink more than expected).

Fields of papers citing papers by Robin J. Lurvink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin J. Lurvink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin J. Lurvink. The network helps show where Robin J. Lurvink may publish in the future.

Co-authorship network of co-authors of Robin J. Lurvink

This figure shows the co-authorship network connecting the top 25 collaborators of Robin J. Lurvink. A scholar is included among the top collaborators of Robin J. Lurvink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin J. Lurvink. Robin J. Lurvink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lansu, Nico, Maaike Nederend, Jeanette H.W. Leusen, et al.. (2025). Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade. Translational Oncology. 59. 102464–102464.
2.
3.
4.
5.
Lurvink, Robin J., Emma C. E. Wassenaar, Checca Bakkers, et al.. (2023). Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery. Scientific Reports. 13(1). 20458–20458. 3 indexed citations
6.
7.
Erning, Felice N. van, et al.. (2023). The impact of body weight on the development of peritoneal metastases in colorectal cancer patients: results from a nationwide cohort study. World Journal of Surgical Oncology. 21(1). 328–328.
8.
Lurvink, Robin J., Checca Bakkers, V.E.P.P. Lemmens, et al.. (2022). The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study. Surgical Endoscopy. 36(9). 6551–6557. 3 indexed citations
9.
Koemans, Willem J., Robin J. Lurvink, Cecile Grootscholten, et al.. (2021). Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort. Gastric Cancer. 24(4). 800–809. 57 indexed citations
10.
Lurvink, Robin J., Kurt Van der Speeten, Koen P. Rovers, & Ignace H. J. T. de Hingh. (2021). The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review. Journal of Gastrointestinal Oncology. 12(S1). S259–S270. 19 indexed citations
11.
Rovers, Koen P., Emma C. E. Wassenaar, Robin J. Lurvink, et al.. (2021). Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC). Annals of Surgical Oncology. 28(9). 5311–5326. 37 indexed citations
12.
Bakkers, Checca, Robin J. Lurvink, Simon W. Nienhuijs, et al.. (2021). Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study. Annals of Surgical Oncology. 28(13). 9073–9083. 29 indexed citations
13.
14.
15.
Lurvink, Robin J., Ignace H. J. T. de Hingh, Tom van Wezel, et al.. (2020). Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases. European Journal of Surgical Oncology. 46(10). 1925–1931. 5 indexed citations
16.
Erve, Iris van ’t, Koen P. Rovers, Karen Bolhuis, et al.. (2020). Abstract 708: Limited release of circulating tumor DNA into the systemic circulation by peritoneal metastases from colorectal cancer. Cancer Research. 80(16_Supplement). 708–708. 3 indexed citations
17.
18.
Lurvink, Robin J., Koen P. Rovers, Ignace H. J. T. de Hingh, & Maarten J. Deenen. (2020). ASO Author Reflection: Systemic Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy with Oxaliplatin in Patients with Colorectal Peritoneal Metastases. Annals of Surgical Oncology. 27(S3). 799–800. 1 indexed citations
19.
Bakkers, Checca, Rudi M. H. Roumen, Robin J. Lurvink, et al.. (2020). Incidence, risk factors, treatment, and survival of ovarian metastases of colorectal origin: a Dutch population-based study. International Journal of Colorectal Disease. 35(6). 1035–1044. 14 indexed citations
20.
Lurvink, Robin J., Checca Bakkers, Felice N. van Erning, et al.. (2020). Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study. European Journal of Surgical Oncology. 47(5). 1026–1033. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koen P. Rovers Breakdown of academic impact, for papers by Alexander Kerscher Breakdown of academic impact, for papers by Isabelle Sourrouille Breakdown of academic impact, for papers by Uwe Maeder Breakdown of academic impact, for papers by A. Garofalo Breakdown of academic impact, for papers by Elia Poiasina Breakdown of academic impact, for papers by François-Noël Gilly Breakdown of academic impact, for papers by Tommaso Cioppa Breakdown of academic impact, for papers by Eva V. E. Madsen Breakdown of academic impact, for papers by Stylianos Giassas
Rankless by CCL
2026